BioCatalyst

Amlitelimab, SIGE, Gluten-free product (GFP) — catalyst calendar

1 verified catalyst event(s) referencing Amlitelimab, SIGE, Gluten-free product (GFP), each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-08-05
in 1mo
ESTIMATED
 READOUT
A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adu
Phase 2 · Coeliac Disease, Celiac Disease
 SNY Sanofi Amlitelimab, SIGE, Gluten-free product ( ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.